Precipio Inc

Research Precipio Inc (PRPO) on Bullrun: market cap USD 43.40M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPRPO
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyUSD
• Market capUSD 43.40M
• Financial periodFY2025
• RevenueUSD 24.25M
• Revenue growth30.5%
• Net income-USD 363.00K
• Free cash flowUSD 359.00K
• Gross margin44.2%

Valuation Snapshot

latest market cap is USD 43.40M.

About Precipio Inc

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

Frequently asked questions

What is Precipio Inc's market cap?

Precipio Inc's market capitalization is USD 43.40M.

What does Precipio Inc do?

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels;